The Bone Marrow Transplant (BMT) and Cellular Therapy Program at Rush offers stem cell and bone marrow transplantation to patients who have hematologic cancers, such as leukemia and lymphoma, and other blood diseases.
We offer the full spectrum of transplant options, including cord blood transplantation and autologous and allogenic stem cell transplantations.
At Rush, you can expect our BMT specialists to take a holistic approach to your care. That means that in addition to providing the most advanced treatments available, your care team will focus on your quality of life before, during and after treatment. We have a dedicated team of physicians, advanced practice providers, nurses, dietitians, pharmacists, transplant nurse coordinators, financial specialists and social workers.
We also have a dedicated BMT psychologist who can partner with you and your loved ones to address the physical, emotional and social challenges associated with these treatments throughout your care.
Rush’s fast-track BMT clinic helps you to smoothly transition from the inpatient to outpatient care. Housed in the inpatient BMT unit at Rush University Medical Center, the fast-track clinic is an outpatient clinic for our BMT patients who are experiencing any side effects or setbacks.
The clinic is open year round, including weekends and holidays — providing the care you need, when you need it.
Excellence in Bone Marrow Transplant and Cellular Therapy
A leader in quality
Rush is accredited by the Foundation for the Accreditation of Cellular Therapy (FACT) — the highest level of accreditation that recognizes Rush’s compliance with quality standards for cell collection, laboratory processing and transplantation.
Additionally, as confirmed by the Center for International Blood and Marrow Transplant Research registry, Rush is at 100 percent survival for the first 180 days after transplant.
Cord blood transplantations
The BMT program at Rush provides cord blood transplants, which opens up transplant opportunities for all patients who do not have a donor match through their family or the national marrow donor program.
CAR-T cell therapy
Rush offers CAR-T cell therapy to patients who have multiply relapsed refractory lymphoma or acute lymphoblastic leukemia.
"Our providers and staff at every level are passionate about patient care and committed to serving our patients."
Celalettin Ustun, MD
Chair, Section of Bone Marrow Transplant and Cell Therapy